TripSitter Clinic Ltd announced on November 11 the closing of its acquisition of assets of Insight Systems, PBC, doing business as Reconscious Medical. The deal was originally announced on March 22, 2022.
The assets of Reconscious Medical will be instrumental in the future growth plans of the TripSitter Clinic. Reconscious Medical will be integrating their technology platform created specific to virtual psychedelic psychotherapy with TripSitter Clinic’s telehealth delivery system. Terms of the deal were not disclosed.
Reconscious Medical is a psychedelic psychotherapy company engaging in both in-clinic and online virtual care with safety, monitoring and support provided through a proprietary technology platform. Reconscious Medical’s primary focus and service to date has been combining psychedelic treatment with psychotherapy in both high and low doses of ketamine.
TripSitter Clinic, through its wholly owned subsidiary TripSitter Clinic Corp, is at the forefront of two emerging sectors: telehealth and psychedelic medicine. The company offers a consultative virtual clinic and telehealth platform that connects prospective patients to a licensed physician who can evaluate for a prescribed treatment program of low-dose, oral ketamine medication.
According to the LevinPro HC database, this marks the 24th acquisition in the infusion services subsector of the year, as of November 11, 2022. This is a significant increase over the same 2021 period, when there were only 10 transactions in the subsector.
